A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src
Caterina Bianco1, Luigi Strizzi, Aasia Rehman
1Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
Human Cripto-1 (CR-1) is a member of the epidermal growth factor-Cripto FRL1 Cryptic family that has been shown to function as a coreceptor with the type I Activin serine-threonine kinase receptor ALK4 for the transforming growth factor beta-related peptide Nodal. However, CR-1 can also activate the mitogen-activated protein kinase and Akt pathways independently of Nodal and ALK4 by an unknown mechanism. Here, we demonstrate that CR-1 specifically binds to Glypican-1, a membrane-associated heparan sulfate proteoglycan, and activates the tyrosine kinase c-Src, triggering the mitogen-activated protein kinase and Akt signaling pathways. Finally, an active Src kinase is necessary for CR-1 to induce in vitro transformation and migration in mouse mammary epithelial cells.
Insights
Human Cripto-1 (CR-1) binds Glypican-1, activating Src kinase to promote cell growth and migration. This discovery reveals a novel signaling pathway for CR-1 independent of Nodal and ALK4.
Area of Science:
- Molecular and Cellular Biology
- Cancer Research
- Developmental Biology
Background:
- Human Cripto-1 (CR-1) is a growth factor involved in development.
- CR-1 acts as a coreceptor with ALK4 for the Nodal signaling pathway.
- CR-1 can activate MAPK and Akt pathways independently of Nodal and ALK4 through an unknown mechanism.
Purpose of the Study:
- To elucidate the mechanism by which CR-1 activates signaling pathways independently of Nodal and ALK4.
- To identify the direct binding partners of CR-1 involved in these alternative signaling pathways.
- To determine the role of Src kinase in CR-1-mediated cellular processes.
Main Methods:
- Co-immunoprecipitation assays to identify CR-1 binding partners.
- Western blotting to detect activation of MAPK, Akt, and Src kinases.
- In vitro cell transformation and migration assays using mouse mammary epithelial cells.
Main Results:
- CR-1 specifically binds to Glypican-1, a heparan sulfate proteoglycan.
- CR-1 binding to Glypican-1 activates the tyrosine kinase c-Src.
- Activated Src kinase is essential for CR-1-induced cell transformation and migration.
Conclusions:
- CR-1 utilizes Glypican-1 as a receptor to activate the Src tyrosine kinase.
- The CR-1-Glypican-1-Src axis represents a novel signaling pathway.
- Targeting this pathway may offer new therapeutic strategies for cancers involving CR-1.
Related Concept Videos
Intracellular Signaling Cascades
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Non-Canonical Wnt Signaling Pathways


